Zenotech Lab Peer Comparison

BSE: 532039

₹44.90

₹-0.18 (-0.40%)

As on 28-Aug-2026 13:54IST

Market cap

₹278 Cr

Revenue (TTM)

₹45 Cr

P/E Ratio

P/B Ratio

2.9

Div. Yield

0 %

Edit

	Zenotech Lab	JB Chemicals	Pfizer	Caplin Point Lab	Astrazeneca Pharma
Market cap (₹ Cr)	278	38,731	21,704	19,251	17,850
Revenue (₹ Cr)	45	4,148	2,570	2,287	2,432
Net Profit (₹ Cr)	-2.52	709.47	735.15	678.07	169.62
Net Margin (%)	-5.39	16.85	26.88	28.10	6.90
RoE (%)	-2.55	19.11	19.16	19.73	20.76
Price to Earnings	--	54.59	29.52	28.93	105.24
Price-To-Book	2.93	9.31	4.92	5.11	19.74

Income Statement (₹ Cr)

	Zenotech Lab	JB Chemicals	Pfizer	Caplin Point Lab	Astrazeneca Pharma
Operating Revenue	43.61	4,147.79	2,519.65	1,937.47	2,275.58
Total Income	45.92	4,209.62	2,707.60	2,033.90	2,304.07
Total Expenditure	34.43	3,042.03	1,615.47	1,290.54	2,013.55
EBITDA	9.19	1,105.76	904.18	646.93	262.03
Depreciation	7.11	182.50	57.73	65.96	28.58
EBIT	2.08	923.26	846.45	580.97	233.45
Interest	--	5.57	9.57	0.61	4.49
Other Income	2.31	61.82	187.95	96.43	28.49
Exceptional Items	-0.20	-27.18	-49.16	--	-5.25
Profit before Tax	4.19	952.34	975.67	676.78	252.20
Provision for Tax	5.26	242.86	253.24	135.69	64.68
Profit after Tax	-1.07	709.47	722.43	541.09	187.52

	Zenotech Lab	JB Chemicals	Pfizer	Caplin Point Lab	Astrazeneca Pharma
Shareholder's Funds	95.12	4,159.22	4,202.90	2,850.49	872.79
Minority Interest	--	--	--	35.90	--
Non-Current Liabilities	3.98	679.04	19.19	13.24	394.49
Current Liabilities	12.06	1,037.35	627.48	305.99	1,109.50
Total Liabilities	111.15	5,875.61	4,921.88	3,207.85	2,414.58

	Zenotech Lab	JB Chemicals	Pfizer	Caplin Point Lab	Astrazeneca Pharma
Non-Current Assets	70.11	2,520.05	1,046.35	1,071.67	509.16
Current Assets	41.04	3,355.56	3,803.22	2,133.95	1,859.88
Total Assets	111.15	5,875.61	4,921.88	3,207.85	2,414.58
Total Debt*	0.00	0.00	2.50	0.55	0.00
Net Current Assets	28.98	2,318.21	3,175.74	1,827.96	750.38
Contingent Liabilities	1.05	106.98	370.49	0.64	121.23

	Zenotech Lab	JB Chemicals	Pfizer	Caplin Point Lab	Astrazeneca Pharma
Cash From Operating Activities	10.20	703.92	967.57	432.37	-15.14
Cash Flow from Investing Activities	-6.49	-585.88	-561.67	-334.73	18.69
Cash from Financing Activities	--	-123.10	-798.31	-38.32	-91.97
Net Cash Inflow / Outflow	3.71	-5.05	-392.41	59.32	-88.42

	Zenotech Lab	JB Chemicals	Pfizer	Caplin Point Lab	Astrazeneca Pharma
ROCE (%)	4.38	25.19	23.39	26.22	31.24
ROE (%)	-1.12	19.11	17.16	21.72	23.02
ROA (%)	-0.98	13.01	14.91	18.37	8.90
EBIT Margin (%)	26.36	28.15	43.34	38.37	12.77
Net Margin (%)	-2.33	16.85	26.68	26.60	8.14
Cash Profit Margin (%)	13.85	20.80	29.72	31.33	9.47

	Zenotech Lab	JB Chemicals	Pfizer	Caplin Point Lab	Astrazeneca Pharma
Revenue Growth (%)	1.32	5.87	10.45	14.37	32.59
EBIT Growth (%)	-26.90	9.10	19.68	20.21	-1.38
Net Profit Growth (%)	-119.10	7.56	-5.88	17.27	62.02
EPS Growth (%)	-119.10	4.29	-5.88	17.25	62.02
Book Value Growth (%)	-1.05	27.38	-0.34	23.77	13.51

	Zenotech Lab	JB Chemicals	Pfizer	Caplin Point Lab	Astrazeneca Pharma
Price / Earnings	0.00	46.69	29.89	28.38	103.45
Price / Book Value	2.20	7.96	5.14	5.52	22.39
Dividend Yield (%)	0.00	1.07	1.59	0.30	0.46
EV/EBITDA	15.56	28.25	16.93	19.78	65.23
Market Cap (₹ Cr)	209.28	33,126.34	21,592.90	15,219.80	19,398.64

	Zenotech Lab	JB Chemicals	Pfizer	Caplin Point Lab	Astrazeneca Pharma
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	--	0.00	0.00	0.00	--
Current Ratio	3.40	3.23	6.06	6.97	1.68
Quick Ratio	3.40	2.58	5.31	5.88	0.75
Interest Coverage	--	172.03	102.95	1,110.48	57.17

	Zenotech Lab	JB Chemicals	Pfizer	Caplin Point Lab	Astrazeneca Pharma
Debtors to sales (%)	20.12	18.83	7.22	32.65	9.39
Asset Turnover	0.40	0.79	0.54	0.66	1.08
Receivable days	67.92	67.92	26.06	110.70	31.88
Inventory Days	0.00	51.58	65.95	65.86	126.03
Payable days	1,263.19	112.87	81.01	105.88	163.79
Cash Conversion Cycle	-1,217.81	6.63	11.00	70.68	-5.88

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.